CompletedNot Applicable

Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)

United States126 participantsStarted 2004-06

Plain-language summary

This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy (PML). We will focus on the role of inflammation in PML, and define prognostic markers of disease evolution.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Presence of opportunistic brain lesions other than PML. ( e.g., toxoplasmosis, lymphoma)
✕. Presence of confounding neurological disorder such as brain neoplasm etc.
✕. Medically unstable or hematological, renal, or hepatic dysfunction.
✕. Cardiac pacemaker
✕. Internal clips,
✕. Metal implants, or external clips with 10 mm of the head.
✕. Metal in the eyes.
✕. Pregnant

Trial details

NCT IDNCT01132053

SponsorBeth Israel Deaconess Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-09

View on ClinicalTrials.gov More Progressive Multifocal Leukoencephalopathy trials